CYANOGENIC GLYCOSIDES AS A POTENTIAL BIOREGULATOR
DOI:
https://doi.org/10.15414/jmbfs.2016.6.1.743-746Keywords:
Amygdalin, cyanogenic glycosides, apoptosis, mTOR pathwayAbstract
Natural substances which are considered to be a food that provides medical and health benefits are called bioregulator. Bioregulators can be used in medicine for preventing and treating migraine, hypertension, chronic inflammation, and other reaction source diseases. Amygdalin is considered for one of the most important bioregulator. It is a controversial nature cyanogenic glycoside abundant in the seeds of Rosaceae family. The family includes herbs, shrubs, and trees and most species are deciduous, but some are evergreen. In the past few years, has been a renewed interest about distribution of Rosaceae fruits because amygdalin has been used for many years in traditional and alternative medicine. Therefore, it is included in regulatory pathways and processes. Recent data indicate potential regulatory activity of amygdalin in signaling pathways of highly metastatic cells, suggesting that amygdalin might not only be an innovative tool to neutralize metastatic dissemination but also to complement mTOR-inhibitor based regimens.Downloads
Download data is not yet available.
Downloads
Published
2016-08-01
How to Cite
Michalcová, K., Halenár, M., & Kolesárová, A. (2016). CYANOGENIC GLYCOSIDES AS A POTENTIAL BIOREGULATOR. Journal of Microbiology, Biotechnology and Food Sciences, 6(1), 743–746. https://doi.org/10.15414/jmbfs.2016.6.1.743-746
Issue
Section
Biotechnology
License
Copyright (c) 2016 KatarÃÂna Michalcová, Marek Halenár, Adriana Kolesárová
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers published in the Journal of Microbiology, Biotechnology and Food Sciences are published under a CC-BY licence (CC-BY 4.0). Published materials can be shared (copy and redistribute the material in any medium or format) and adapted (remix, transform, and build upon the material for any purpose, even commercially) with specifying the author(s).